𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New liposomal formulation of vincristine for non-Hodgkin’s lymphoma

✍ Scribed by Anya M Hillery

Book ID
114401872
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
48 KB
Volume
3
Category
Article
ISSN
1461-5347

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced non-Hodgkin's lymp
Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion
✍ Don V. Jackson Jr; Eugene H. Paschold; Charles L. Spurr; Hyman B. Muss; Fred Ric 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Twenty-five patients with a variety of histologic types of advanced non-Hodgkin's lymphoma refractory to previous chemotherapy were entered into a trial of vincristine infusion. Patients received 5-day courses of vincristine 0.25 mg/m2/day by continuous intravenous infusion after an initial 0.5 mg i

Mitoxantrone, prednimustine, and vincris
Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma
✍ Yau, Jonathan C.; Germond, Colin; Gluck, Stefan; Cripps, Christine; Verma, Shail 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Elderly patients with intermediate-or high-grade non-Hodgkin's lymphoma have a worse outcome than those who are younger than 60 years. It has been shown that aggressive combination chemotherapy is poorly tolerated in older patients resulting in a subsequent decrease in dose intensity. A phase II tri